Related Experiment Videos
[Long-term experiences with continuous peridural opiate analgesia with an implanted pump]
Der Anaesthesist
|September 1, 1984
Summary
Continuous epidural opiate analgesia using implantable pumps offers effective chronic pain relief for cancer patients. This method demonstrated safety and efficacy over a year, with no observed side-effects or tolerance development.
Area of Science:
- Pain Management
- Neurosurgery
- Oncology
Context:
- Chronic pain in malignant conditions presents significant challenges.
- Epidural opiate administration is a common analgesic strategy.
- Existing methods may have limitations in long-term efficacy and patient convenience.
Purpose:
- To evaluate the efficacy and safety of continuous epidural opiate analgesia delivered via an implantable, percutaneously refillable pump.
- To compare this continuous infusion method with on-demand bolus injections of epidural opiates.
- To assess long-term outcomes, including side-effects, tolerance, and technical complications.
Summary:
- Six patients with chronic malignant pain received continuous epidural opiate analgesia via implantable pumps.
- The treatment was effective and well-tolerated over one year, with no side-effects or tolerance.
- No hygienic or technical implantation issues arose; post-mortem analyses confirmed device integrity and local compatibility.
Impact:
- Establishes a new, effective, and safe method for managing chronic malignant pain.
- Demonstrates the long-term viability of implantable pump systems for continuous epidural analgesia.
- Provides a valuable treatment option for patients with intractable cancer-related pain, improving quality of life.